MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants.
Double-strand breaks (DSBs) constitute the most deleterious form of DNA lesions that can lead to genome alterations and cell death, and the vast majority of DSBs arise pathologically in response to DNA damaging agents such as ionizing radiation (IR) and chemotherapeutic agents. Recent studies have i...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3762724?pdf=render |
| _version_ | 1818246454361194496 |
|---|---|
| author | Xiling Wu Yang Xu Katey Feng Joshua D Tompkins Chengtao Her |
| author_facet | Xiling Wu Yang Xu Katey Feng Joshua D Tompkins Chengtao Her |
| author_sort | Xiling Wu |
| collection | DOAJ |
| description | Double-strand breaks (DSBs) constitute the most deleterious form of DNA lesions that can lead to genome alterations and cell death, and the vast majority of DSBs arise pathologically in response to DNA damaging agents such as ionizing radiation (IR) and chemotherapeutic agents. Recent studies have implicated a role for the human MutS homologue hMSH5 in homologous recombination (HR)-mediated DSB repair and the DNA damage response. In the present study, we show that hMSH5 promotes HR-based DSB repair, and this property resides in the carboxyl-terminal portion of the protein. Our results demonstrate that DSB-triggered hMSH5 chromatin association peaks at the proximal regions of the DSB and decreases gradually with increased distance from the break. Furthermore, the DSB-triggered hMSH5 chromatin association is preceded by and relies on the assembly of hMRE11 and hRad51 at the proximal regions of the DSB. Lastly, the potential effects of hMSH5 non-synonymous variants (L85F, Y202C, V206F, R351G, L377F, and P786S) on HR and cell survival in response to DSB-inducing anticancer agents have been analyzed. These experiments show that the expression of hMSH5 variants elicits different survival responses to anticancer drugs cisplatin, bleomycin, doxorubicin and camptothecin. However, the effects of hMSH5 variants on survival responses to DSB-inducing agents are not directly correlated to their effects exerted on HR-mediated DSB repair, suggesting that the roles of hMSH5 variants in the processes of DNA damage response and repair are multifaceted. |
| first_indexed | 2024-12-12T14:49:04Z |
| format | Article |
| id | doaj.art-d1c4c12ea2434773a64dcbd8228917da |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T14:49:04Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d1c4c12ea2434773a64dcbd8228917da2022-12-22T00:21:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7328410.1371/journal.pone.0073284MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants.Xiling WuYang XuKatey FengJoshua D TompkinsChengtao HerDouble-strand breaks (DSBs) constitute the most deleterious form of DNA lesions that can lead to genome alterations and cell death, and the vast majority of DSBs arise pathologically in response to DNA damaging agents such as ionizing radiation (IR) and chemotherapeutic agents. Recent studies have implicated a role for the human MutS homologue hMSH5 in homologous recombination (HR)-mediated DSB repair and the DNA damage response. In the present study, we show that hMSH5 promotes HR-based DSB repair, and this property resides in the carboxyl-terminal portion of the protein. Our results demonstrate that DSB-triggered hMSH5 chromatin association peaks at the proximal regions of the DSB and decreases gradually with increased distance from the break. Furthermore, the DSB-triggered hMSH5 chromatin association is preceded by and relies on the assembly of hMRE11 and hRad51 at the proximal regions of the DSB. Lastly, the potential effects of hMSH5 non-synonymous variants (L85F, Y202C, V206F, R351G, L377F, and P786S) on HR and cell survival in response to DSB-inducing anticancer agents have been analyzed. These experiments show that the expression of hMSH5 variants elicits different survival responses to anticancer drugs cisplatin, bleomycin, doxorubicin and camptothecin. However, the effects of hMSH5 variants on survival responses to DSB-inducing agents are not directly correlated to their effects exerted on HR-mediated DSB repair, suggesting that the roles of hMSH5 variants in the processes of DNA damage response and repair are multifaceted.http://europepmc.org/articles/PMC3762724?pdf=render |
| spellingShingle | Xiling Wu Yang Xu Katey Feng Joshua D Tompkins Chengtao Her MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. PLoS ONE |
| title | MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. |
| title_full | MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. |
| title_fullStr | MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. |
| title_full_unstemmed | MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. |
| title_short | MutS homologue hMSH5: recombinational DSB repair and non-synonymous polymorphic variants. |
| title_sort | muts homologue hmsh5 recombinational dsb repair and non synonymous polymorphic variants |
| url | http://europepmc.org/articles/PMC3762724?pdf=render |
| work_keys_str_mv | AT xilingwu mutshomologuehmsh5recombinationaldsbrepairandnonsynonymouspolymorphicvariants AT yangxu mutshomologuehmsh5recombinationaldsbrepairandnonsynonymouspolymorphicvariants AT kateyfeng mutshomologuehmsh5recombinationaldsbrepairandnonsynonymouspolymorphicvariants AT joshuadtompkins mutshomologuehmsh5recombinationaldsbrepairandnonsynonymouspolymorphicvariants AT chengtaoher mutshomologuehmsh5recombinationaldsbrepairandnonsynonymouspolymorphicvariants |